Literature DB >> 16007414

The Pro12Ala and C-681G variants of the PPARG locus are associated with opposing growth phenotypes in young schoolchildren.

J E Cecil1, B Fischer, A S F Doney, M Hetherington, P Watt, W Wrieden, C Bolton-Smith, C N A Palmer.   

Abstract

AIMS/HYPOTHESIS: Peroxisome proliferator-activated receptor gamma is an important regulator of adiposity in mouse and man, and common variation in the PPARG gene has been associated with birthweight, adult obesity, insulin sensitivity and type 2 diabetes. We hypothesised that these variants may be associated with childhood obesity.
METHODS: Height and weight were recorded for 2454 prepubertal children aged between 4 and 10 years, who were then genotyped for three common variants of the PPARG locus: C-681G, Pro12Ala and C1431T.
RESULTS: No single variant of PPARG was significantly associated with height, weight or BMI. However, when modelling the variants together we detected an opposing interaction between the -681G and the Ala12 variants in height and weight, but not BMI (p=0.018, 0.013 and 0.119 respectively). The data were consistent with the Ala12 carriers being deficient in energy storage/utilisation, leading to reduced growth. In contrast, the -681G variant, which has been associated with increased adult height, was associated with accelerated growth. The two variants were in strong linkage disequilibrium. However, rare individuals bearing the isolated variants demonstrated the greatest variation from the mean, the most contrasting genotypes being associated with a variation of 7 kg in weight and 6 cm in height, standardised to 7.4-year-olds (p=0.006 and p=0.02 respectively). CONCLUSIONS/
INTERPRETATION: This study demonstrates that quantitative trait analysis of energy balance/growth and the PPARG locus is complex and requires the use of multiple genetic markers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007414     DOI: 10.1007/s00125-005-1817-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  36 in total

1.  C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway.

Authors:  Evan D Rosen; Chung-Hsin Hsu; Xinzhong Wang; Shuichi Sakai; Mason W Freeman; Frank J Gonzalez; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

2.  A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans.

Authors:  A Meirhaeghe; L Fajas; N Helbecque; D Cottel; P Lebel; J Dallongeville; S Deeb; J Auwerx; P Amouyel
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

3.  Evidence for gene-nutrient interaction at the PPARgamma locus.

Authors:  J Luan; P O Browne; A H Harding; D J Halsall; S O'Rahilly; V K Chatterjee; N J Wareham
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

Review 4.  PPARgamma, the ultimate thrifty gene.

Authors:  J Auwerx
Journal:  Diabetologia       Date:  1999-09       Impact factor: 10.122

5.  Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction.

Authors:  Paul M Ridker; Nancy R Cook; Suzanne Cheng; Henry A Erlich; Klaus Lindpaintner; Jorge Plutzky; Robert Y L Zee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-03-27       Impact factor: 8.311

6.  Peroxisome proliferator-activated receptor gamma C161-->T polymorphism and coronary artery disease.

Authors:  X L Wang; J Oosterhof; N Duarte
Journal:  Cardiovasc Res       Date:  1999-12       Impact factor: 10.787

7.  Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?

Authors:  P W Franks; J Luan; P O Browne; A-H Harding; S O'Rahilly; V K K Chatterjee; N J Wareham
Journal:  Metabolism       Date:  2004-01       Impact factor: 8.694

8.  A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.

Authors:  S S Deeb; L Fajas; M Nemoto; J Pihlajamäki; L Mykkänen; J Kuusisto; M Laakso; W Fujimoto; J Auwerx
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

9.  Body mass index reference curves for the UK, 1990.

Authors:  T J Cole; J V Freeman; M A Preece
Journal:  Arch Dis Child       Date:  1995-07       Impact factor: 3.791

10.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06
View more
  12 in total

1.  Patterns of association between PPARgamma genetic variation and indices of adiposity and insulin action in African-Americans and whites: the CARDIA Study.

Authors:  Qi Wei; David R Jacobs; Pamela J Schreiner; David S Siscovick; Michael W Steffes; Myriam Fornage
Journal:  J Mol Med (Berl)       Date:  2006-09-06       Impact factor: 4.599

2.  Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population.

Authors:  Alexey G Nikitin; Dimitry A Chistiakov; Larissa O Minushkina; Dmitry A Zateyshchikov; Valery V Nosikov
Journal:  Heart Vessels       Date:  2010-05-29       Impact factor: 2.037

Review 3.  PPARgamma in human and mouse physiology.

Authors:  Sami Heikkinen; Johan Auwerx; Carmen A Argmann
Journal:  Biochim Biophys Acta       Date:  2007-03-27

4.  BMI at age 8 years is influenced by the type 2 diabetes susceptibility genes HHEX-IDE and CDKAL1.

Authors:  Christiane Winkler; Ezio Bonifacio; Harald Grallert; Lydia Henneberger; Thomas Illig; Anette-Gabriele Ziegler
Journal:  Diabetes       Date:  2010-05-11       Impact factor: 9.461

Review 5.  Biomarkers of obesity and subsequent cardiovascular events.

Authors:  Salma Musaad; Erin N Haynes
Journal:  Epidemiol Rev       Date:  2007-05-10       Impact factor: 6.222

6.  Association of the peroxisome proliferator-activated receptor-gamma2 Pro12Ala but not the C1431T gene variants with lower body mass index in Type 2 diabetes.

Authors:  M Ben Hadj Mohamed; N Mtiraoui; I Ezzidi; M Chaieb; T Mahjoub; W Y Almawi
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

7.  Lack of association of type 2 diabetes susceptibility genotypes and body weight on the development of islet autoimmunity and type 1 diabetes.

Authors:  Christiane Winkler; Jennifer Raab; Harald Grallert; Anette-Gabriele Ziegler
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

8.  Accounting for a quantitative trait locus for plasma triglyceride levels: utilization of variants in multiple genes.

Authors:  Lisa J Martin; Ahmed H Kissebah; Michael Olivier
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

9.  Association of peroxisome proliferator-activated receptor α/δ/γ with obesity, and gene-gene interaction, in the Chinese Han population.

Authors:  Wenshu Luo; Zhirong Guo; Ming Wu; Chao Hao; Xiaoshu Hu; Zhengyuan Zhou; Zhiwu Zhou; Xingjuan Yao; Lijun Zhang; Jingchao Liu
Journal:  J Epidemiol       Date:  2013-04-01       Impact factor: 3.211

10.  A co-association network analysis of the genetic determination of pig conformation, growth and fatness.

Authors:  Anna Puig-Oliveras; Maria Ballester; Jordi Corominas; Manuel Revilla; Jordi Estellé; Ana I Fernández; Yuliaxis Ramayo-Caldas; Josep M Folch
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.